Hca Healthcare is a medical care facility company located in Tennessee, United States, which is part of the Healthcare sector, and is traded under the ticker HCA on the NYSE exchange.
Hca Healthcare stock last closed at $488.27, up 1.19% from the previous day, and has increased 45.92% in one year. It has overperformed other stocks in the Medical Care Facilities industry by 1.07 percentage points. Hca Healthcare stock is currently +65.52% from its 52-week low of $295.00, and -7.45% from its 52-week high of $527.56.
There are currently 228.19M HCA shares outstanding. The market capitalization of HCA is $111.42B. In the past 24 hours, 954,000 HCA shares were traded.
You will need an online brokerage account in order to access the NYSE market and buy HCA shares.
Based on our analysis, eToro is the best place to buy stocks. Here's why:
Get $10 towards your stock purchase by creating an account with eToro now. This offer is only for US users.
Open eToro AccountNow that you've chosen the right brokerage, you'll need to fill out some personal information so you can invest in HCA today.
Now that you've filled out your info on our top ranked stock trading app, you can securely and quickly fund your account:
Check out the walkthrough below to see the process of depositing funds into your investment account.
After you have chosen the best place to buy Hca Healthcare stock, it's very important to analyze their stock prior to buying, so you can wrap your head around the risk and upside.
WallStreetZen was designed to help average investors do better fundamental analysis in less time.
You can see all of the due diligence checks on HCA's stock page.
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge HCA's intrinsic value.
Using relative valuations ratios:
You can access more valuation research on HCA's stock here.
Out of 17 Wall Street analysts who give recommendations on HCA, the consensus analyst rating on HCA is a Buy
It's important to note that analyst ratings are not stock recommendations, nor are they investment advice.
Matthew Gillmor, a top 20% analyst from KeyBanc maintains HCA with a strong buy rating and raises their HCA price target from $500.00 to $550.00, on Jan 28, 2026.
KeyBanc's Matthew Gillmor raised their price target on Hca Healthcare (NYSE: HCA) by 10% from $500 to $550 on 2026/01/28. The analyst maintained their Strong Buy rating on the stock.
HCA Healthcare reported its Q4 and FY 2025 earnings.
Strong core earnings and upside from Medicaid SDPs contributed to the company's 2% EBITDA beat, which Gillmor described as "very solid."
Further, significant efficiency initiatives and underlying EBITDA growth momentum underpinned management's 2026 estimate of $16B, which was significantly higher than the buy-side's $15.6B to $15.7B, the analyst noted.
HCA Healthcare reported:
For Q4 2025:
For FY 2025:
For FY 2026, management guided:
CEO Sam Hazen commented: "We finished 2025 with strong performance consistent with previous quarters.
“Our investments in network expansion, workforce development, and advancing clinical capabilities further strengthened the HCA Healthcare system.
“I want to thank our colleagues for their outstanding work, their dedication to our patients, and their unyielding commitment to our mission.”
Michael Wiederhorn, a bottom 9% analyst from Oppenheimer maintains HCA with a buy rating and raises their HCA price target from $500.00 to $540.00, on Jan 28, 2026.
David S Macdonald, a top 11% analyst from Truist Securities maintains HCA with a strong buy rating and raises their HCA price target from $520.00 to $546.00, on Jan 28, 2026.
Pito Chickering, a top 22% analyst from Deutsche Bank maintains HCA with a strong buy rating and raises their HCA price target from $500.00 to $558.00, on Jan 28, 2026.
Ann Hynes, a top 10% analyst from Mizuho maintains HCA with a buy rating and raises their HCA price target from $505.00 to $520.00, on Dec 18, 2025.
You can dig deeper into what analysts are projecting on the Hca Healthcare stock forecast page.
Last year, HCA earnings were $6.34B. During the last 5 year, HCA's earnings have gone up by 21.13% per year. This was faster than the Medical Care Facilities industry average of 17.36%.
Last year, HCA revenue was $74.37B. In the past 5 year, HCA's revenue has gone up by 7.94% per year. This was slower than the Medical Care Facilities industry average of 8.92%.
You can research HCA's earnings and revenue performance here.
Over the last year, insiders at HCA have bought more shares than they have sold.
Michael R. McAlevey, EVP Chief Legal Admin Off. of HCA, was the latest HCA insider to sell. They sold $1,843,990.68 worth of HCA shares on Nov 5, 2025.
Dig into more about who owns HCA shares here.
Hca Healthcare pays a dividend of 0.59%, compared to the Medical Care Facilities industry's average dividend yield of 1.35%. If you owned $1,000 worth of HCA stock, you would have received $5.90 in the past year.
Hca Healthcare dividend payments have consistently grown over the past decade but have not remained stable.
Find more data about Hca Healthcare dividend yield and history here.
One of the primary reasons eToro is our favorite brokerage is because of its social trading community.
Click below to find out what other community members have to say.
There are two primary order types:
Hit the Open button and eToro will place your order.
If you require additional help with investing in stocks on eToro, watch the how to video below:
Now that you own some HCA shares, you'll want to keep up with your shares.
Make a watchlist to get notified of important updates regarding your HCA stock.
To summarize, here are the 6 steps you need to take to buy Hca Healthcare stock right now:
If you are looking for a place to buy stocks, eToro is our favorite venue.
Get Started with eToro TodayIf you want to keep an eye on your new investment in Hca Healthcare, get started below.